BioLineRx (BLRX) Non-cash Items (2013 - 2025)

BioLineRx's Non-cash Items history runs 13 years deep, the most recent figure standing at -$6.0 million for Q4 2025.

• In Q4 2025, Non-cash Items rose 82.55% year-over-year to -$6.0 million; the TTM figure through Dec 2025 stood at -$6.0 million (up 82.55% YoY), while the FY2025 annual figure was -$6.0 million, up 82.55% from the prior year.
• Non-cash Items was -$6.0 million for Q4 2025 at BioLineRx, down from -$5.1 million in the prior quarter.
• In the past five years, Non-cash Items ranged from a high of $38.0 million in Q4 2023 to a low of -$34.7 million in Q4 2024.
• Historically, Non-cash Items has averaged -$2.1 million across 5 years, with a median of -$1.3 million in 2022.
• The sharpest annual moves came in 2021 and 2024: Non-cash Items soared 4361.29% in 2021, then plunged 423.52% in 2024.
• A 5-year view of Non-cash Items shows it stood at $4.7 million in 2021, then slumped by 127.54% to -$1.3 million in 2022, then soared by 3048.49% to $38.0 million in 2023, then plunged by 191.18% to -$34.7 million in 2024, then soared by 82.55% to -$6.0 million in 2025.
• The last three Non-cash Items figures came in at -$6.0 million (Q4 2025), -$5.1 million (Q3 2025), and -$5.3 million (Q2 2025), per Business Quant data.